Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia
- 31 May 1995
- journal article
- Published by Elsevier in Metabolism
- Vol. 44 (5) , 589-596
- https://doi.org/10.1016/0026-0495(95)90115-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patientsActa Diabetologica, 1994
- Prospective analysis of the insulin-resistance syndrome (syndrome X)Diabetes, 1992
- The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemiaMetabolism, 1990
- Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Relationship between lipoprotein levels and in vivo insulin action in normal young white menMetabolism, 1988
- Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemiaDiabetes, 1988
- Hypertriglyceridemia and carbohydrate intolerance: Interrelations and therapeutic implicationsThe American Journal of Cardiology, 1986
- Resistance to insulin but not to glucagon in lean human hypertriglyceridemicsDiabetes, 1980
- Reappraisal of the role of insulin in hypertriglyceridemiaThe American Journal of Medicine, 1974